Follows Announcement Earlier this Week that Ampligen Co-Founder and Former AIM CEO Agreed to Join Scientific Advisory Board if Kellner Group Nominees Are Elected Kellner Group Reiterates Plan to ...

CureGene Pharmaceutical ("CureGene"), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antiviral disease, proudly announces the ...

A low-calorie, high-protein diet reduced anxiety and depression symptoms after 15 days and stress after 30 days in obese ...

The company said the unanticipated events of pericardial effusion--when fluid builds up in the space around the heart--came in the Phase 2 clinical trial of 3 milligrams per kilogram and 4.6 mg/kg ...

As a result of the preliminary STOMP data – which gave the chances of a positive outcome from the study at less than 1% – the ...

Scientists comment on new legislation on regulatory frameworks for clinical trials, as laid out by UK Parliament. Dr Catriona Manville, Director of Research Policy at the Association of Medical ...

Keros will host an update call and webcast today, December 12, 2024, at 8:00 a.m. ET LEXINGTON, Mass., Dec. 12, 2024 (GLOBE ...

The £100 million investment in the new CRDCs represents a major step in making cutting-edge treatments more accessible to ...

When Sue Vincent was diagnosed with advanced ovarian cancer, she was told she could have just months to live - until a miracle drug changed everything ...

A visionary mentor and team builder, Pramod Kumar Voola has distinguished himself through his exceptional ability to develop ...

Scientists at the ICR have discovered 21 drug candidates since 2005, of which 13 have entered clinical trials in collaboration with industry partners ...

A new study led by investigators from Mass General Brigham has identified a unique brain network that links varied patterns of brain atrophy, or shrinkage, associated with schizophrenia.